'
The related resources bookmark allows you to jump directly to other pages on the site that contain information directly related to the topics you're currently exploring.
- Home Page
- What's New?
- Tumor Types
- Molecular Causes of Cancer
- Biological Pathways
- Therapeutic Targets
- Pipeline Molecules
- Research Education
- Research ADCs
- Research Apoptosis
- Research B cell
- Research BRAF
- Research Cancer Immunotherapy
- Research HDIs
- Research HER Pathways
- Research MET
- Research VEGF
- Clinical Trials
- Resources
- Contact Us
Share
Prognostic indicators
- Despite advancements in the treatment of DLBCL, approximately half of patients relapse after treatment or are refractory to treatment3,28
- A greater understanding of the biology of DLBCL and an assessment of favorable or poor prognosis may facilitate better treatment decisions in the future, ultimately resulting in improved patient outcomes28
- Investigative efforts to define patient subsets associated with favorable or unfavorable prognoses focus on both clinical and molecular factors28